Why Large Capital Projects Need a Different Operating Model In large pharmaceutical capital projects, speed is always a priority. But one part of the process still tends to slow everything down: commissioning, qualification and validation. The issue is not expertise. It is the way CQV is still often organised. On complex projects, paper-based workflows, sequential…
When Validation Becomes the Bottleneck Read More »
A leading pharmaceutical client, using Kneat since 2019, partnered with No deviation for a critical upgrade from version 8.8 to 9.3. Their goal: improve system performance, usability, and compliance. The result: a smooth and compliant transition. What We Delivered User Requirement Specification (URS): Defining expectations and user needs. Functional Risk Assessment (FRA): Identifying key risks
Case Study: How No deviation Helped Achieve a Smooth Kneat Upgrade (v8.8 to v9.3) Read More »
Digital Validation Takes Center Stage April 2025 marks a major milestone in the pharmaceutical and life sciences industries: the publication of ISPE’s Good Practice Guide: Digital Validation. This long-anticipated resource provides clear, actionable guidance on transitioning from traditional paper-based validation to fully integrated Digital Validation Tools (DVTs). At No deviation, we’re particularly proud of this
ISPE’s Good Practice Guide is out — and No deviation Is Proudly Involved Read More »
No deviation, a patient-centric solution provider for the pharmaceutical industry is pleased to announce its partnership with Kneat Solutions, the leading validation software solution for the life sciences sector. The partnership between No deviation and Kneat Solutions enables them to work strategically with organizations to comprehensively map, configure, optimise and digitise work processes to KneatGx™,
2 Venture Drive, #08-10/11,
Vision Exchange
Singapore 608526